Singapore markets close in 38 minutes

Cyclerion Therapeutics, Inc. (CYCN)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.2105-0.2095 (-6.13%)
At close: 01:37PM EDT
3.4700 +0.26 (+8.08%)
After hours: 05:36PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 7.74M
Enterprise value -46.22M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)55.50
Price/book (mrq)1.50
Enterprise value/revenue -655.82
Enterprise value/EBITDA 1.58

Trading information

Stock price history

Beta (5Y monthly) 1.82
52-week change 3-82.92%
S&P500 52-week change 311.79%
52-week high 319.8000
52-week low 32.7670
50-day moving average 33.5170
200-day moving average 37.3149

Share statistics

Avg vol (3-month) 38.73k
Avg vol (10-day) 37.07k
Shares outstanding 52.41M
Implied shares outstanding 62.41M
Float 81.29M
% held by insiders 113.80%
% held by institutions 144.96%
Shares short (14 Sept 2023) 418.62k
Short ratio (14 Sept 2023) 41.87
Short % of float (14 Sept 2023) 41.10%
Short % of shares outstanding (14 Sept 2023) 40.77%
Shares short (prior month 14 Aug 2023) 425.84k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:20
Last split date 315 May 2023

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)29 Jun 2023


Profit margin 0.00%
Operating margin (ttm)-4,809.21%

Management effectiveness

Return on assets (ttm)-80.67%
Return on equity (ttm)-189.09%

Income statement

Revenue (ttm)608k
Revenue per share (ttm)0.28
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -29.21M
Net income avi to common (ttm)-28.85M
Diluted EPS (ttm)-12.2600
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)5.64M
Total cash per share (mrq)2.34
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)1.44
Book value per share (mrq)2.14

Cash flow statement

Operating cash flow (ttm)-29.73M
Levered free cash flow (ttm)-19.7M